Effect of vitamin K₂ treatment on carboxylation of osteocalcin in early postmenopausal women

References

• Szulc P, Chapuy M C, Meunier P J, Delmas P D. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993; 91: 1769–1774
   PubMed Web of Science ®Google Scholar
• Szulc P, Arlot M, Chapuy M C, Duboeuf F, Meunier P J, Delmas P D. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 1994; 9: 1591–1595
   PubMed Web of Science ®Google Scholar
• Seibel M J, Robins S P, Bilezikian J P. Serum undercarboxylated osteocalcin and the risk of hip fracture. J Clin Endocrinol Metab 1997; 82: 717–718
   Google Scholar
• Vergnaud P, Garnero P, Meunier P J, Breart G, Kamihagi K, Delmas P D. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS study. J Clin Endocrinol Metab 1997; 82: 719–724
   PubMed Web of Science ®Google Scholar
• Shearer M J. The roles of vitamins D and K in bone health and osteoporosis prevention. Proc Nutr Soc 1997; 56: 915–937
   PubMed Web of Science ®Google Scholar
• Shiraki M, Shiraki Y, Aoki C, Miura M. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 2000; 15: 515–521
   PubMed Web of Science ®Google Scholar
• Iwamoto J, Takeda T, Ichimura S. Effect of menatetrenone on bone mineral density and incidence of vertebral fractures in postmenopausal women with osteoporosis: a comparison with the effect of etidronate. J Orthop Sci 2001; 6: 487–492
   PubMedGoogle Scholar
• Plantalech L, Guillaumont M, Vergnaud P, Leclercq M, Delmas P D. Impairment of γ carboxylation of circulating osteocalcin (bone Gla protein) in elderly women. J Bone Miner Res 1991; 6: 1211–1216
   PubMed Web of Science ®Google Scholar
• Takahashi M, Naitou K, Ohishi T, Kushida K, Miura M. Effect of vitamin K and/or D on undercarboxylated and intact osteocalcin in osteoporotic patients with vertebral or hip fractures. Clin Endocrinol (Oxf) 2001; 54: 219–224
   Google Scholar
• Ushiroyama T, Ikeda A, Ueki M. Effect of continuous combined therapy with vitamin K2 and vitamin D3 on bone mineral density and coagulofibrinolysis function in postmenopausal women. Maturitas 2002; 41: 211–221
   Google Scholar
• Orimo H, Sugioka Y, Fukunaga M, Muto Y, Hotokebuchi T, Gorai I, Nakamura T, Kushida K, Tanaka H, Ikai T, et al. Diagnostic criteria of primary osteoporosis. J Bone Miner Metab 1998; 16: 139–150
   Web of Science ®Google Scholar
• Nakatsuka K, Miki T, Nishizawa Y, Tabata T, Inoue T, Morii H, Ogata E. Circulating bone Gla-protein in end-stage renal disease determined by newly developed two-site immunoradiometric assay. H Morii. Karger, Basel 1991; 147–154, Contributions in Nephrology
   Google Scholar
• Gomez B, Ardakani S, Ju J, Jenkins D, Cerelli M J, Daniloff G Y, Kung V T. Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin Chem 1995; 41: 1560–1566
   PubMed Web of Science ®Google Scholar
• Robins S P, Woitge H, Hesley R, Ju J, Seyedin S, Seibel M J. Direct enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 1994; 9: 1643–1649
   PubMed Web of Science ®Google Scholar
• Yasui T, Yamada M, Kinoshita H, Uemura H, Yoneda N, Irahara M, Aono T, Sunahara S, Mito Y, Kurimoto F, et al. Combination of automatic HPLC–RIA method for determination of estrone and estradiol in serum. J Clin Lab Anal 1999; 13: 266–272
   Google Scholar
• Ozuru R, Sugimoto T, Yamaguchi T, Chihara K. Time-dependent effects of vitamin K2 (menatetrenone) on bone metabolism in postmenopausal women. Endocr J 2002; 49: 363–370
   PubMed Web of Science ®Google Scholar
• Koshihara Y, Hoshi K. Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J Bone Miner Res 1997; 12: 431–438
   PubMed Web of Science ®Google Scholar
• Akedo Y, Hosoi T, Inoue S, Ikegami A, Mizuno Y, Kaneki M, Nakamura T, Ouchi Y, Orimo H. Vitamin K2 modulates proliferation and function of osteoblastic cells in vitro. Biochem Biophys Res Commun 1992; 187: 814–820
   Google Scholar
• Hara K, Akiyama Y, Tajima T, Shiraki M. Menatetrenone bone resorption partly through the inhibition of PGE2 synthesis in vitro. J Bone Miner Res 1991; 8: 535–542
   Google Scholar
• Akiyama Y, Hara K, Tajima T, Murota S, Morita I. Effect of vitamin K2 (menatetrenone) on osteoclast-like cell formation in mouse bone marrow cultures. Eur J Pharmacol 1994; 263: 181–185
   Google Scholar
• Kameda T, Miyazawa K, Mori Y, Yuasa T, Shiokawa M, Nakamura Y, Mano H, Hakeda Y, Kameda A, Kumegawa M. Vitamin K2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochem Biophys Res Commun 1996; 220: 515–519
   PubMed Web of Science ®Google Scholar
• Orimo H, Fujita T, Onomura T, Inoue T, Kushida K, Shiraki M. Clinical evaluation of Ea-0167 (menatetrenone) in the treatment of osteoporosis. Clin Eval 1992; 20: 45–100
   Google Scholar
• Shiraishi A, Takeda S, Masaki T, Higuchi Y, Uchiyama Y, Kubodera N, Sato K, Ikeda K, Nakamura T, Matsumoto T, et al. Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen. J Bone Miner Res 2000; 15: 770–779
   PubMed Web of Science ®Google Scholar
• Chen J T, Shiraki M, Hasumi K, Tanaka N, Katase K, Kato T, Hirai Y, Nakamura T, Ogata E. 1-α-Hydroxyvitamin D3 treatment decreases bone turnover and modulates calcium-regulating hormones in early postmenopausal women. Bone 1997; 20: 557–562
   PubMed Web of Science ®Google Scholar
• Koshihara Y, Hoshi K, Ishibashi H, Shiraki M. Vitamin K2 promotes 1,25(OH)2vitamin D3-induced mineralization in human periosteal osteoblasts. Calcif Tissue Int 1996; 59: 466–473
   Google Scholar
• Matsunaga S, Ito H, Sakou T. The effect of vitamin K and D supplementation on ovariectomy-induced bone loss. Calcif Tissue Int 1999; 65: 285–289
   PubMedGoogle Scholar
• Meunier P J. Calcium, vitamin D and vitamin K in the prevention of fractures due to osteoporosis. Osteoporos Int 1999; 9: S48–S52
   Google Scholar
• Orimo H, Shiraki M, Fujita T, Onohara T, Inoue T, Kushida K. Clinical evaluation of menatetrenone in the treatment of involutional osteoporosis – a double-blind multi-center comparative study with 1α-hydroxy vitamin D3. J Bone Miner Res 1992; 7: S122
   Google Scholar
• Hodges S J, Akesson K, Vergnaud P, Obrant K, Delmas P D. Circulating levels of vitamins K1 and K2 decreased in elderly women with hip fracture. J Bone Miner Res 1993; 8: 1241–1245
   PubMed Web of Science ®Google Scholar
• Booth S L, Tucker K L, Chen H, Hannan M T, Gagnon D R, Cupples L A, Wison P WF, Ordovas J, Schaefer E J, Dawson-Hughes B, et al. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr 2000; 71: 1201–1208
   PubMed Web of Science ®Google Scholar
• Feskanich D, Weber P, Willett W C, Rockett H, Booth S L, Colditz G A. Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr 1999; 69: 74–79
   PubMed Web of Science ®Google Scholar
• Kaneki M, Hedges S J, Hosoi T, Fujiwara S, Lyons A, Crean J, Ishida N, Nakagawa M, Takechi M, Sano Y, et al. Japanese fermented soybean food as the major determinant of the large geographic difference in circulating levels of vitamin K2: possible implications for hip-fracture risk. Nutrition 2001; 17: 315–321
   PubMed Web of Science ®Google Scholar